Evaluationoof0theoRole0ofoGabapentin0and/oroOmega-30in0Uremic Pruritusofor0PatientsoUndergoing0Hemodialysis0

Sinan Forat Hussein; Kadhim Ali Kadhim; Ali Jassim Al_Sultani; Saad Abdulrahman Hussain

doi:10.32947/ajps.v17i2.157

Evaluationoof0theoRole0ofoGabapentin0and/oroOmega-30in0Uremic Pruritusofor0PatientsoUndergoing0Hemodialysis0

Authors

Sinan Forat Hussein Babil Directorate of Health, Babil, Iraq.
Kadhim Ali Kadhim Department of Clinical Pharmacy ,College of Pharmacy, University of Mustansiriyah.
Ali Jassim Al_Sultani Babil Directorate of Health, Babil, Iraq.
Saad Abdulrahman Hussain Faculty of Pharmacy, Alrafidain University College, Baghdad, Iraq

DOI:

https://doi.org/10.32947/ajps.v17i2.157

Keywords:

Gabapentin, Omega-3, Uremic Pruritus, Hemodialysis

Abstract

Uremicopruritus,0isochronic0itchingothat0occursoin0patientsowith0advancedoor0 end-stage renal0disease.oIt0isoone0ofocommon0symptomsoinopatients00with00end-stage renal0 diseaseowith0approximatelyo60–90%0ofopatients0on0hemodialysis(HD) suffering0fromothis0problem. This study wasodesigned0to evaluate theoefficacy0and safety of prescribing Gabapentinoand0Omega-3 in combination or aloneofor0relieving uremicopruritus0in Iraqi patients undergoing0hemodialysis. The resultsoshowed0that all the threeoinvolved0regimens0(gabapentin, omega-3,0and the combinationoof0both drugs) had0significantly reduced the pruritus score. Furthermore,0theocombination0was significantlyosuperior0tooother0regimens in reducingopruritus 0score, owhile0no0significant effect0wasoobserved0by oallothe regimensoon0interleukin-6oor0on parathyroid hormone serum0levels.In Conclusion Gabapentin0100mgoplus01000mg0omega-30based fishooil capsules containing 120mg0DHA and0180mg0EPA isosuperior0to each drug alone0in reducing pruritus scoreoin0a0sample0of Iraqi0patients.

Downloads

Published

2017-12-01

How to Cite

Hussein, S. F., Kadhim, K. A., Al_Sultani, A. J., & Hussain, S. A. (2017). Evaluationoof0theoRole0ofoGabapentin0and/oroOmega-30in0Uremic Pruritusofor0PatientsoUndergoing0Hemodialysis0. Al Mustansiriyah Journal of Pharmaceutical Sciences, 17(2), 123–131. https://doi.org/10.32947/ajps.v17i2.157

Issue

Vol. 17 No. 2 (2017): Volume 17, Issue 2. 2017

Section

Articles

License

AJPS is an open-access journal that all contents are free of charge. Articles of this journal are licensed under the terms of the Creative Commons Attribution International Public License CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/legalcode) that licensees are unrestrictly allowed to search, download, share, distribute, print, or link to the full texts of the articles, crawl them for indexing and reproduce any medium of the articles provided that they give the author(s) proper credits (citation). The journal allows the author(s) to retain the copyright of their published article.

Creative Commons-Attribution (BY)